Literature DB >> 20602484

The face of Noonan syndrome: Does phenotype predict genotype.

Judith E Allanson1, Axel Bohring, Helmuth-Guenther Dörr, Andreas Dufke, Gabrielle Gillessen-Kaesbach, Denise Horn, Rainer König, Christian P Kratz, Kerstin Kutsche, Silke Pauli, Salmo Raskin, Anita Rauch, Anne Turner, Dagmar Wieczorek, Martin Zenker.   

Abstract

The facial photographs of 81 individuals with Noonan syndrome, from infancy to adulthood, have been evaluated by two dysmorphologists (JA and MZ), each of whom has considerable experience with disorders of the Ras/MAPK pathway. Thirty-two of this cohort have PTPN11 mutations, 21 SOS1 mutations, 11 RAF1 mutations, and 17 KRAS mutations. The facial appearance of each person was judged to be typical of Noonan syndrome or atypical. In each gene category both typical and unusual faces were found. We determined that some individuals with mutations in the most commonly affected gene, PTPN11, which is correlated with the cardinal physical features, may have a quite atypical face. Conversely, some individuals with KRAS mutations, which may be associated with a less characteristic intellectual phenotype and a resemblance to Costello and cardio-facio-cutaneous syndromes, can have a very typical face. Thus, the facial phenotype, alone, is insufficient to predict the genotype, but certain facial features may facilitate an educated guess in some cases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20602484      PMCID: PMC3115585          DOI: 10.1002/ajmg.a.33518

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  27 in total

1.  Genotype-phenotype correlations in Noonan syndrome.

Authors:  Martin Zenker; Gernot Buheitel; Ralf Rauch; Rainer Koenig; Kirstin Bosse; Wolfram Kress; Hans-Ulrich Tietze; Helmuth-Guenther Doerr; Michael Hofbeck; Helmut Singer; André Reis; Anita Rauch
Journal:  J Pediatr       Date:  2004-03       Impact factor: 4.406

2.  No reason yet to change diagnostic criteria for Noonan, Costello and cardio-facio-cutaneous syndromes.

Authors:  G Neri; J Allanson; M I Kavamura
Journal:  J Med Genet       Date:  2008-12       Impact factor: 6.318

3.  Germline gain-of-function mutations in SOS1 cause Noonan syndrome.

Authors:  Amy E Roberts; Toshiyuki Araki; Kenneth D Swanson; Kate T Montgomery; Taryn A Schiripo; Victoria A Joshi; Li Li; Yosuf Yassin; Alex M Tamburino; Benjamin G Neel; Raju S Kucherlapati
Journal:  Nat Genet       Date:  2006-12-03       Impact factor: 38.330

4.  Noonan and cardio-facio-cutaneous syndromes: two clinically and genetically overlapping disorders.

Authors:  A-M Nyström; S Ekvall; E Berglund; M Björkqvist; G Braathen; K Duchen; H Enell; E Holmberg; U Holmlund; M Olsson-Engman; G Annerén; M-L Bondeson
Journal:  J Med Genet       Date:  2008-05-02       Impact factor: 6.318

5.  Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome.

Authors:  Caroline Nava; Nadine Hanna; Caroline Michot; Sabrina Pereira; Nathalie Pouvreau; Tetsuya Niihori; Yoko Aoki; Yoichi Matsubara; Benoit Arveiler; Didier Lacombe; Eric Pasmant; Béatrice Parfait; Clarisse Baumann; Delphine Héron; Sabine Sigaudy; Annick Toutain; Marlène Rio; Alice Goldenberg; Bruno Leheup; Alain Verloes; Hélène Cavé
Journal:  J Med Genet       Date:  2007-08-17       Impact factor: 6.318

6.  Molecular and clinical characterization of cardio-facio-cutaneous (CFC) syndrome: overlapping clinical manifestations with Costello syndrome.

Authors:  Yoko Narumi; Yoko Aoki; Tetsuya Niihori; Giovanni Neri; Hélène Cavé; Alain Verloes; Caroline Nava; Maria Ines Kavamura; Nobuhiko Okamoto; Kenji Kurosawa; Raoul C M Hennekam; Louise C Wilson; Gabriele Gillessen-Kaesbach; Dagmar Wieczorek; Pablo Lapunzina; Hirofumi Ohashi; Yoshio Makita; Ikuko Kondo; Shigeru Tsuchiya; Etsuro Ito; Kiyoko Sameshima; Kumi Kato; Shigeo Kure; Yoichi Matsubara
Journal:  Am J Med Genet A       Date:  2007-04-15       Impact factor: 2.802

7.  SOS1 is the second most common Noonan gene but plays no major role in cardio-facio-cutaneous syndrome.

Authors:  Martin Zenker; Denise Horn; Dagmar Wieczorek; Judith Allanson; Silke Pauli; Ineke van der Burgt; Helmuth-Guenther Doerr; Harald Gaspar; Michael Hofbeck; Gabriele Gillessen-Kaesbach; Andreas Koch; Peter Meinecke; Stefan Mundlos; Anja Nowka; Anita Rauch; Silke Reif; Christian von Schnakenburg; Heide Seidel; Lars-Erik Wehner; Christiane Zweier; Susanne Bauhuber; Verena Matejas; Christian P Kratz; Christoph Thomas; Kerstin Kutsche
Journal:  J Med Genet       Date:  2007-06-23       Impact factor: 6.318

8.  Germline gain-of-function mutations in RAF1 cause Noonan syndrome.

Authors:  M Abdur Razzaque; Tsutomu Nishizawa; Yuta Komoike; Hisato Yagi; Michiko Furutani; Ryunosuke Amo; Mitsuhiro Kamisago; Kazuo Momma; Hiroshi Katayama; Masao Nakagawa; Yuko Fujiwara; Masaki Matsushima; Katsumi Mizuno; Mika Tokuyama; Hamao Hirota; Jun Muneuchi; Toru Higashinakagawa; Rumiko Matsuoka
Journal:  Nat Genet       Date:  2007-07-01       Impact factor: 38.330

9.  Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair.

Authors:  Viviana Cordeddu; Elia Di Schiavi; Len A Pennacchio; Avi Ma'ayan; Anna Sarkozy; Valentina Fodale; Serena Cecchetti; Alessio Cardinale; Joel Martin; Wendy Schackwitz; Anna Lipzen; Giuseppe Zampino; Laura Mazzanti; Maria C Digilio; Simone Martinelli; Elisabetta Flex; Francesca Lepri; Deborah Bartholdi; Kerstin Kutsche; Giovanni B Ferrero; Cecilia Anichini; Angelo Selicorni; Cesare Rossi; Romano Tenconi; Martin Zenker; Daniela Merlo; Bruno Dallapiccola; Ravi Iyengar; Paolo Bazzicalupo; Bruce D Gelb; Marco Tartaglia
Journal:  Nat Genet       Date:  2009-08-16       Impact factor: 38.330

10.  Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy.

Authors:  Bhaswati Pandit; Anna Sarkozy; Len A Pennacchio; Claudio Carta; Kimihiko Oishi; Simone Martinelli; Edgar A Pogna; Wendy Schackwitz; Anna Ustaszewska; Andrew Landstrom; J Martijn Bos; Steve R Ommen; Giorgia Esposito; Francesca Lepri; Christian Faul; Peter Mundel; Juan P López Siguero; Romano Tenconi; Angelo Selicorni; Cesare Rossi; Laura Mazzanti; Isabella Torrente; Bruno Marino; Maria C Digilio; Giuseppe Zampino; Michael J Ackerman; Bruno Dallapiccola; Marco Tartaglia; Bruce D Gelb
Journal:  Nat Genet       Date:  2007-07-01       Impact factor: 38.330

View more
  22 in total

1.  Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation.

Authors:  Talita M Marin; Kimberly Keith; Benjamin Davies; David A Conner; Prajna Guha; Demetrios Kalaitzidis; Xue Wu; Jessica Lauriol; Bo Wang; Michael Bauer; Roderick Bronson; Kleber G Franchini; Benjamin G Neel; Maria I Kontaridis
Journal:  J Clin Invest       Date:  2011-02-21       Impact factor: 14.808

2.  Phenotypic spectrum of 80 Greek patients referred as Noonan syndrome and PTPN11 mutation analysis: the value of initial clinical assessment.

Authors:  Anna Papadopoulou; Michalis Issakidis; Evangelia Gole; Konstantina Kosma; Helen Fryssira; Andreas Fretzayas; Polyxeni Nicolaidou; Sophia Kitsiou-Tzeli
Journal:  Eur J Pediatr       Date:  2011-05-18       Impact factor: 3.183

3.  Congenital Chylothorax as the Initial Presentation of PTPN11-Associated Noonan Syndrome.

Authors:  Darius Ebrahimi-Fakhari; Eli Freiman; Monica H Wojcik; Katie Krone; Alicia Casey; Ariel S Winn; Amy E Roberts; Beth D Harper
Journal:  J Pediatr       Date:  2017-03-28       Impact factor: 4.406

4.  RASopathies: Clinical Diagnosis in the First Year of Life.

Authors:  M C Digilio; F Lepri; A Baban; M L Dentici; P Versacci; R Capolino; R Ferese; A De Luca; M Tartaglia; B Marino; B Dallapiccola
Journal:  Mol Syndromol       Date:  2011-09-14

5.  A Novel SHOC2 Variant in Rasopathy.

Authors:  Vickie Hannig; Myoungkun Jeoung; Eun Ryoung Jang; John A Phillips; Emilia Galperin
Journal:  Hum Mutat       Date:  2014-09-11       Impact factor: 4.878

6.  Noonan syndrome in diverse populations.

Authors:  Paul Kruszka; Antonio R Porras; Yonit A Addissie; Angélica Moresco; Sofia Medrano; Gary T K Mok; Gordon K C Leung; Cedrik Tekendo-Ngongang; Annette Uwineza; Meow-Keong Thong; Premala Muthukumarasamy; Engela Honey; Ekanem N Ekure; Ogochukwu J Sokunbi; Nnenna Kalu; Kelly L Jones; Julie D Kaplan; Omar A Abdul-Rahman; Lisa M Vincent; Amber Love; Khadija Belhassan; Karim Ouldim; Ihssane El Bouchikhi; Anju Shukla; Katta M Girisha; Siddaramappa J Patil; Nirmala D Sirisena; Vajira H W Dissanayake; C Sampath Paththinige; Rupesh Mishra; Eva Klein-Zighelboim; Bertha E Gallardo Jugo; Miguel Chávez Pastor; Hugo H Abarca-Barriga; Steven A Skinner; Eloise J Prijoles; Eben Badoe; Ashleigh D Gill; Vorasuk Shotelersuk; Patroula Smpokou; Monisha S Kisling; Carlos R Ferreira; Leon Mutesa; Andre Megarbane; Antonie D Kline; Amy Kimball; Emmy Okello; Peter Lwabi; Twalib Aliku; Emmanuel Tenywa; Nonglak Boonchooduang; Pranoot Tanpaiboon; Antonio Richieri-Costa; Ambroise Wonkam; Brian H Y Chung; Roger E Stevenson; Marshall Summar; Kausik Mandal; Shubha R Phadke; María G Obregon; Marius G Linguraru; Maximilian Muenke
Journal:  Am J Med Genet A       Date:  2017-07-27       Impact factor: 2.802

7.  MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation.

Authors:  Xue Wu; Jeremy Simpson; Jenny H Hong; Kyoung-Han Kim; Nirusha K Thavarajah; Peter H Backx; Benjamin G Neel; Toshiyuki Araki
Journal:  J Clin Invest       Date:  2011-02-21       Impact factor: 14.808

Review 8.  Feedback regulation of RTK signaling in development.

Authors:  Cynthia L Neben; Megan Lo; Natalia Jura; Ophir D Klein
Journal:  Dev Biol       Date:  2017-10-26       Impact factor: 3.582

9.  A rasopathy phenotype with severe congenital hypertrophic obstructive cardiomyopathy associated with a PTPN11 mutation and a novel variant in SOS1.

Authors:  Jill A Fahrner; Aisha Frazier; Suha Bachir; Michael F Walsh; Carolyn D Applegate; Reid Thompson; Marc K Halushka; Anne M Murphy; Meral Gunay-Aygun
Journal:  Am J Med Genet A       Date:  2012-05-14       Impact factor: 2.802

Review 10.  Noonan syndrome.

Authors:  Amy E Roberts; Judith E Allanson; Marco Tartaglia; Bruce D Gelb
Journal:  Lancet       Date:  2013-01-10       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.